Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia

Circulation

Volumn 103, Issue 17, 2001, Pages 2138-2143

  Vale, Peter R ^a   Losordo, Douglas W ^a,c   Milliken, Charles E ^a   McDonald, Maria C ^a   Gravelin, Laura M ^a   Curry, Cynthia M ^a   Esakof, Darryl D ^a   Maysky, Michael ^a   Symes, James F ^a   Isner, Jeffrey M ^a,b,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Vascular Genetics

^c ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

Catheters; Gene therapy; Mapping

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NOGA SYSTEM; PLACEBO; PLASMID DNA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN C;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE TRANSFER; HEART CATHETER; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HUMAN; LEFT VENTRICULAR ELECTROMECHANICAL MAPPING; MALE; PERFORATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 6644223710     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.17.2138     Document Type: Article

References (19)

1. Tsurumi Y, Takeshita S, Chen D, et al. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation. 1996;94: 3281-3290.
2. Tio RA, Tkebuchava T, Scheuermann TH, et al. Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium. Hum Gene Ther. 1999;10:2953-2960.
3. 165 following intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation. 1998;97:1114-1123.
4. Isner JM, Baumgartner I, Rauh G, et al. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J Vasc Surg. 1998; 28:964-975.
5. Symes JF, Losordo DW, Vale PR, et al. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease: preliminary clinical results. Ann Thorac Surg. 1999;68:830-837.
6. 165 gene transfer for therapeutic angiogencsis in chronic myocardial ischemia. Circulation. 2000;102:965-974.
7. Ben-Haim SA, Osadchy D, Schuster I, et al. Nonfluoroscopic, in vivo navigation and mapping technology. Nat Med. 1996;2:1393-1395.
8. Gepstein L, Hayam G, Ben-Haim SA. A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart: in vitro and in vivo accuracy results. Circulation. 1997;95:1611-1622.
9. Vale PR, Losordo DW, Tkebuchava T, et al. Catheter-based myocardial gene transfer utilizing nonfluoroscopic electromechanical left ventricular mapping. J Am Coll Cardiol. 1999;34:246-254.
10. Gepstein L, Goldin A, Lessick J, et al. Electromechanical characterization of chronic myocardial infarction in the canine coronary occlusion model. Circulation. 1998;98:2055-2064.
11. Komowski R, Hong MK, Gepstein L, et al. Preliminary animal and clinical experiences using an electromechanical endocardial mapping procedure to distinguish infarcted from healthy myocardium. Circulation. 1998;98:1116-1124.
12. Germano G, Erel J, Lewin H, et al. Automatic quantitation of regional myocardial wall motion and thickening from gated technetium-99 m sestamibi myocardial perfusion single-photon emission computed tomography, J Am Coll Cardiol. 1997;30:1360-1367.
13. Kornowski R, Leon MB, Fuchs S, et al. Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy. J Am Coll Cardiol. 2000;35:1031-1039.
14. Giordano FJ, Ping P, McKirnan D, et al. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nat Med. 1996;2:534-539.
15. Frazier OH, March RJ, Horvath KA, et al. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. N Engl J Med. 1999;341:1021-1028.
16. Allen KB, Dowling RD, Fudge TL, et al. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N Engl J Med. 1999;341:1029-1036.
17. Aaberge L, Nordstrand K, Dragsund M, et al. Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris: clinical results from the Norwegian randomized trial. J Am Coll Cardiol. 2000;35:1170-1177.
18. Kornowski R, Baim DS, Moses JW, et al. Short- and intermediate-term clinical outcomes from direct myocardial laser revascularization guided by Biosense left ventricular electromechanical mapping. Circulation. 2000;102:1120-1125.
19. Vale PR, Milliken CE, Tkebuchava T, et al. Catheter-based gene transfer of VEGF utilizing electromechanical LV mapping accomplishes therapeutic angiogenesis: pre-clinical studies in swine. Circulation. 1999;100: 1-512. Abstract.